Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Bright Minds Biosciences
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
Today 11:56 EST
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
March 04, 2025
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
February 24, 2025
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
January 07, 2025
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
November 21, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
November 04, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
October 21, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
AIFF
CSE:DRUG
DRUG
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
October 16, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events
October 03, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
September 19, 2024
From
Bright Minds Biosciences
Via
GlobeNewswire
Tickers
CSE:DRUG
DRUG
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.